skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Find News Releases

  Search For:  
   
  Between these dates:

 
      
      
  Go          
BenchMarks
BenchMarks

    Volume 4, Issue 3

Cancer and the Environment

Media Resources
Noticias en español

Science Behind the News

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
Annual Report to the Nation

caBIG: Connecting the Cancer Community

Past Highlights
Need Help?
News News
News
     Contact the NCI Press Office

  October 15, 2004

Major News Releases

National Cancer Institute Announces Major Commitment to Nanotechnology for Cancer Research
(Posted: 09/13/2004) - The National Cancer Institute (NCI) announced today at a media briefing a new $144.3 million, five-year initiative to develop and apply nanotechnology to cancer.

Study Suggests Physicians Overperform Surveillance Colonoscopies
(Posted: 08/16/2004) - Physicians appear to be performing surveillance colonoscopies at frequencies higher than those recommended by evidence-based medical guidelines, according to results of a survey conducted by the National Cancer Institute (NCI), part of the National Institutes of Health.

Location of Potential Familial Lung Cancer Gene Discovered
(Posted: 07/26/2004) - Researchers have discovered a possible inherited component for lung cancer, a disease normally associated with external causes, such as cigarette smoking.



Recent News Releases

NIH Announces New Funding for Transdisciplinary Tobacco Use Research Centers
(Posted: 10/13/2004) - The National Institutes of Health (NIH) today announced new funding for the Transdisciplinary Tobacco Use Research Centers (TTURC) initiative, which originally awarded grants to seven research centers in 1999.

Scientists Begin Validation Study of Test to Detect Recurrence of Bladder Cancer
(Posted: 10/04/2004) - A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), at 12 centers* across the United States and Canada. This test was conceived and is being conducted by NCI's Early Detection Research Network (EDRN).

Artificial Neural Networks Can Predict Clinical Outcomes of Neuroblastoma Patients
(Posted: 10/01/2004) - Researchers at the NCI have used artificial neural networks and DNA microarrays to successfully predict the clinical outcome of patients diagnosed with neuroblastoma.

  View Archive

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov